NHS to conduct clinical trials to assess puberty blocker evidence, says Streeting after High Court upholds ban
THE NHS will conduct clinical trials to assess the potential benefits and harms of puberty blockers, Health Secretary Wes Streeting says.
Sir Keir Starmer welcomed Monday’s High Court ruling that an emergency ban on puberty blockers, which suppress the production of sex hormones to delay puberty, was lawful. The ban, imposed by former health secretary Victoria Atkin, had been challenged in court by the TransActual campaign and a young person who cannot be named.
The Prime Minister’s official spokesman told reporters: “The government welcomes the court’s decision. Children’s healthcare must be evidence-led.
More from this author
Long having been considered the ‘US’s backyard,’ Latin America is the crucible of anti-imperialist struggle – yet with the rise of China as an economic and ideological counterweight to Washington, we see a new phase of that struggle emerge, writes BEN CHACKO
Similar stories
GP and co-chair of the Clinical Advisory Network on Sex and Gender LOUISE IRVINE tells Ros Sitwell what the group would like to see in terms of implementing evidence-based healthcare and safeguarding for those experiencing gender issues in the NHS and beyond
